BFC
EXAS

Bedel Financial Consulting’s Exact Sciences EXAS Stock Holding History

Bedel Financial Consulting’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-12
Closed -$1K – 407
2022
Q1 		$1K Hold
12
– – ﹤0.01% 919
2021
Q4 		$1K Hold
12
– – ﹤0.01% 940
2021
Q3 		$1K Hold
12
– – ﹤0.01% 930
2021
Q2 		$1K Hold
12
– – ﹤0.01% 925
2021
Q1 		$2K Buy
+12
New +$1.64K ﹤0.01% 842

Other funds holding EXAS

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Bedel Financial Consulting's EXAS Position: Q2 2022 in Review

Bedel Financial Consulting sold out of Exact Sciences (EXAS) in Q2 2022, closing a stake of 12 shares — an estimated $1K sold.

Bedel Financial Consulting first reported a position in EXAS in Q1 2021 and held it in 5 quarters. The position peaked at $2K in Q1 2021. 501 funds tracked by Wall St. Rank hold EXAS as of Q2 2022.

  • Bedel Financial Consulting reported no remaining Exact Sciences position as of Q2 2022 after selling out during the quarter.
  • Bedel Financial Consulting sold 12 Exact Sciences shares in Q2 2022, an estimated $1K.
  • Bedel Financial Consulting first reported a position in Exact Sciences in Q1 2021 and held it in 5 quarters.
  • Bedel Financial Consulting's Exact Sciences position peaked at $2K in Q1 2021.
  • 501 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2022.

Based on Bedel Financial Consulting's 13F filing for Q2 2022, filed 4 Aug 2022.